Neuroblastoma Australia Grant Round is currently open

Since 2019, Neuroblastoma Australia Scientific Advisory Board has awarded $1.24 million in research grants.  You can see some of the grants in our current projects area.

With the advice of our Scientific Advisory Board, Neuroblastoma Australia is able to fund a range of research projects.  Every two to three years, depending on fundraising success, we seek grant applications from scientists who are passionate about finding kinder and more effective treatments for children diagnosed with neuroblastoma. 

The grant round is now underway with first round Letters of Intent being assessed by our Scientific Advisory Board and scored against set criteria. 

A decision will then be made as to who will be invited to the next stage. The successful researchers will be contacted by June 10 and will have until September 2 to submit their full proposals. Two research proposals will then be announced early December, 2024.

The grants in 2024 will be $150 000 paid over 18 months.

Stage 1 - LOI (NOW CLOSED)

The form to complete and instructions can be found here

LOI deadline, April 30, 2024

Stage 2 - Successful applicants of Stage 1 only

A complete research proposal needs to be submitted. More information on how to submit the research proposal and the necessary components can be found here.

Please also download and complete the Investigator Information form

Research Supported to Date

In recent years Neuroblastoma Australia has supported various research projects with Children’s Cancer Institute, The Peter MacCallum Cancer Centre, UNSW Sydney and Sydney Children’s Hospital, and Cancer Council NSW.

To date Neuroblastoma Australia has funded more than $3 million into neuroblastoma research thanks to the generous support of the community. The 2022 funding round grant pool was $350,000 which we spilt equally between two projects.

Our expert Scientific Advisory Board (SAB) will independently review all research proposals and score them against our Assessment Matrix Proposals and they will be sent to specific specialists as required to also review and provide additional recommendations. Neuroblastoma Australia SAB will review all recommendations to determine which studies will be funded. 

All applications must support the mission of Neuroblastoma Australia:

Our mission is that all children with all types of neuroblastoma survive and lead a long, healthy life, free from the side effects of their treatment. Our focus is raising awareness and fundraising for the research needed to make treatments more targeted, more effective and less toxic.

For more information please contact Lucy Jones.